Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

For Paysafe, Being the ‘Best of the Rest’ Isn’t So Bad

By Chris Markoch, InvestorPlace Contributor

Early investors in PSFE stock are sitting on a loss, but it may be time for investors to see Paysafe as holding a viable, defensible niche.

AMC Entertainment Isn’t Worth $40 a Share Yet

By Chris Markoch, InvestorPlace Contributor

Despite bullish news about rising ticket sales, AMC stock is remaining relatively tame. It may be a sign that investors need more than hype to stay interested.

Stellar Lumens Looks Promising, But That Means Little for the XLM Coin

By Chris Markoch, InvestorPlace Contributor

The MoneyGram deal is bullish for the Stellar Lumens Foundation. I’m just not sure what it does for XLM as a coin.  

Will 5G be the Tide that Lifts AT&T to Wireless Supremacy?

By Chris Markoch, InvestorPlace Contributor

AT&T stock may not go back to its pre-pandemic high. But, if investors can get slow and steady growth from T stock it becomes more intriguing

Tattooed Chef Stock May Benefit From Changing Tastes in the Long Term

By Chris Markoch, InvestorPlace Contributor

Tattooed Chef may be getting a new crop of customers. And if that comes to pass, holding TTCF stock may reward patient, long-term investors

Load More